ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-13

  1. 82 Posts.
    lightbulb Created with Sketch. 4
    itm
    thank you for that info, approval from the EMA could have a positive influence on approvals being granted from other countries. Maybe Dr Smith would be re engaged to further develop marketing in European
    countries.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $2.733K 832.4K

Buyers (Bids)

No. Vol. Price($)
32 45274833 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126718541 16
View Market Depth
Last trade - 15.57pm 09/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.